Nobuaki Matsubara, Arun Azad, Neeraj Agarwal, Fred Saad, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Robert Jones Jones, Stefanie Zschaebitz, Jan Oldenburg, Neal D. Shore, Curtis J Dunshee, Joan Carles, Andre P. Fay, Paul Cislo, Cynthia Healy, Melissa Kirker, Karim Fizazi. "Final patient-reported outcomes (PROs) in unselected men receiving talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as initial treatment for metastatic castration-resistant prostate cancer (mCRPC): Results from the phase 3 TALAPRO-2 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.11120